Parnax Lab, a company in the Pharmaceuticals industry, reported revenue of ₹69 crore and net profit of ₹2.18 crore for the September 2026 quarter.
Parnax Lab (NSE: PARNAXLAB) closed at ₹114.87 on 20 Nov 2026. Its market capitalisation is ₹132 crore and it trades at 15.4 times earnings.
Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.